Results 1 to 10 of about 106,771 (304)

Use of Anti-Asthmatic Medications in Elderly Taiwanese Patients

Kaohsiung Journal of Medical Sciences, 2003
The aim of this study was to assess the use of anti-asthmatic medications in Taiwanese geriatric asthmatic patients. We used computerized prescription databases from the National Health Insurance Program, Taiwan, and classified drugs according to the ...
Chi-Yu Chen
doaj   +3 more sources

Association of asthma and anti-asthmatic therapy with oral health and microbiota alterations in children - a cross-sectional study. [PDF]

BMC Pediatr
Background Asthma and its treatments are recognized as risk factors for oral health in children. The composition of oral microbiota is linked to asthma, as well as to the development of caries and other oral conditions.
Berce V, Egić B, Lonzaric AP, Rupnik M, Mahnic A.   +4 more
europepmc   +2 more sources

Nonsteroidal Anti-Inflammatory Agents in the Treatment of Asthma in Children [PDF]

Canadian Respiratory Journal, 1995
The increasing scientific information clearly demonstrates the important role of inflammation in asthma. This evidence has led physicians to focus their treatment on the elimination of inflammation instead of working solely against bronchoconstriction ...
Pierre Gaudreault
doaj   +2 more sources

A current review on animal models of anti-asthmatic drugs screening [PDF]

Frontiers in Pharmacology
Asthma is a chronic inflammatory respiratory condition characterised by airway constriction, smooth muscle spasm, and severe morbidity. It affects around 300 million people globally, with children being especially vulnerable. Despite its worldwide effect,
Shivam Singh, Sunita Kularia, Shivakshi Shukla, Mithilesh Singh, Manish Kumar, Ashish Kumar Sharma   +5 more
doaj   +2 more sources

Anti-inflammatory and antioxidant effects of Allolobophora caliginosa extract against Ovalbumin-induced airway inflammation in asthmatic female BALB/c mice

Beni-Suef University Journal of Basic and Applied Sciences
Background The chronic inflammatory and immunological disease "Asthma" is characterized by oxidative stress disruptions and is typically treated with glucocorticoids, the most potent anti-inflammatory agents.
Islam Ahmed Abdelmawgood, Tarek Atia, Abeer Mahmoud Badr, Ayman Saber Mohamed, Mennatallah H. Abdelaziz, Noha Ahmed Mahana, Hader Ibrahim Sakr, Reham S. Al-Fakharany, Tamer D. Abdelaziz, Ahmed A. Damanhory, Adel Alghamdi, Marwa Ahmed Abdelfattah, Hadeer Hesham Abdelfattah   +12 more
doaj   +2 more sources

Does bronchial asthma influences dental health of the diseased children? [PDF]

Vojnosanitetski Pregled, 2022
Background/Aim. Asthma is a chronic inflammatory lung disorder. The effect of asthma drugs on oral health is still the subject of debate among researchers in dentistry.
Davidović Bojana, Ivanović Mirjana, Bokonjić Dejan, Janković Svjetlana, Erić Jelena, Lečić Jelena, Jovičić Olivera   +6 more
doaj   +1 more source

Molecular and immunomodulatory actions of new antiasthmatic agents: Exploring the diversity of biologics in Th2 endotype asthma

Pharmacological Research, 2022
Asthma is a major respiratory disorder characterised by chronic inflammation and airway remodelling. It affects about 1–8% of the global population and is responsible for over 461,000 deaths annually.
Emmanuel Oshiogwe Okwuofu, Audrey Chee Hui Yong, Jonathan Chee Woei Lim, Johnson Stanslas   +3 more
doaj   +1 more source

Perception of Illness and Fear of Inhaled Corticosteroid Use among Parents of Children with Asthma

Children, 2023
The most prevalent children’s chronic disease worldwide is asthma which has notable negative impacts on patients’ and parent’s quality of life. Daily inhaled corticosteroids (ICS) therapy is a preferred controller choice.
Jasna Petric Duvnjak, Emilija Lozo Vukovac, Anita Ursic, Antonela Matana, Ivana Medvedec Mikic   +4 more
doaj   +1 more source

Adherence to inhalers and associated factors among adult asthma patients: an outpatient-based study in a tertiary hospital of Rajshahi, Bangladesh

Asthma Research and Practice, 2022
Background Adherence to inhaler medication is an important contributor to optimum asthma control along with adequate pharmacotherapy. The objective of the present study was to assess self-reported adherence levels and to identify the potential factors ...
Md. Abdur Rafi, Chowdhury Ibtida Tahmin, Symom Tashrik, Atia Sharmin Bonna, Ferdousy Jannat, Sabrina Jahan Mily, Abhigan Babu Shrestha, Senjuti Seemanta, Afsana Rashid, Mosarrat Mahjabeen, Nurunnahar Nura, Tasnim Shahriar, Ashrafur Rahaman Mahadi, Kawser Ahmed, Mohammad Jahid Hasan, Md. Azizul Haque, Md. Golam Hossain   +16 more
doaj   +1 more source

Reslizumab versus placebo for poorly controlled, severe eosinophilic asthma: Meta-analysis [PDF]

Vojnosanitetski Pregled, 2018
Background/Aim. Reslizumab is humanized monoclonal antibody produced by recombinant DNA technology which binds to circulating interleukin-5 (IL-5) and down-regulates the IL-5 signaling pathway. Reslizumab is indicated for the add-on maintenance treatment
Milosavljević Miloš N., Janković Slobodan M., Pejčić Ana V., Milovanović Jasmina R., Opančina Valentina D., Kostić Marina J.   +5 more
doaj   +1 more source